127 related articles for article (PubMed ID: 34929228)
21. Expression patterns of ERVWE1/Syncytin-1 and other placentally expressed human endogenous retroviruses along the malignant transformation process of hydatidiform moles.
Bolze PA; Patrier S; Cheynet V; Oriol G; Massardier J; Hajri T; Guillotte M; Bossus M; Sanlaville D; Golfier F; Mallet F
Placenta; 2016 Mar; 39():116-24. PubMed ID: 26992684
[TBL] [Abstract][Full Text] [Related]
22. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
Niemann I; Hansen ES; Sunde L
Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
[TBL] [Abstract][Full Text] [Related]
23. Genetics of gestational trophoblastic disease.
Fisher RA; Maher GJ
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():29-41. PubMed ID: 33685819
[TBL] [Abstract][Full Text] [Related]
24. [Gestational trophoblastic disease, Villous gestational trophoblastic disease].
Vogel M; Horn LC
Pathologe; 2004 Jul; 25(4):269-79. PubMed ID: 15197483
[TBL] [Abstract][Full Text] [Related]
25. Identification of nonsynonymous TP53 mutations in hydatidiform moles.
Chan KK; Wong ES; Wong OG; Ngan HY; Cheung AN
Mutat Res; 2018 May; 809():20-23. PubMed ID: 29655027
[TBL] [Abstract][Full Text] [Related]
26. The Presence of the Autophagic Markers LC3B and Sequestosome 1/p62 in the Hydatidiform Mole.
Karpathiou G; Dridi M; Papoudou-Bai A; Perard M; Clemenson A; Chauleur C; Peoc'h M
Int J Gynecol Pathol; 2023 May; 42(3):301-307. PubMed ID: 35512216
[TBL] [Abstract][Full Text] [Related]
27. Residual trophoblastic disease in association with partial hydatidiform mole.
Szulman AE; Ma HK; Wong LC; Hsu C
Obstet Gynecol; 1981 Mar; 57(3):392-4. PubMed ID: 6258115
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of hydatidiform moles using circulating gestational trophoblasts isolated from maternal blood.
Ravn K; Hatt L; Singh R; Schelde P; Hansen ES; Vogel I; Uldbjerg N; Niemann I; Sunde L
Placenta; 2023 Apr; 135():7-15. PubMed ID: 36889013
[TBL] [Abstract][Full Text] [Related]
29. Trophoblast proliferation rate does not predict progression to persistent gestational trophoblastic disease in complete hydatidiform mole.
Jeffers MD; Richmond JA; Smith R
Int J Gynecol Pathol; 1996 Jan; 15(1):34-8. PubMed ID: 8852444
[TBL] [Abstract][Full Text] [Related]
30. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
[TBL] [Abstract][Full Text] [Related]
31. [Risk factors for gestational trophoblastic tumors following complete hydatidiform mole].
Grzybowski W; Płoszyński A; Mielnik J; Adamcio-Deptulska M; Preis K; Wojciechowska D
Ginekol Pol; 2002 Nov; 73(11):1003-10. PubMed ID: 12722390
[TBL] [Abstract][Full Text] [Related]
32. [Expression of p57 marker in differential diagnosis of complete and partial mole - correlation with DNA analysis].
Cierna Z; Palkovič M; Danihel Ml L; Danihel L; Repiská V; Vojtaššák J; Korbeľ M
Cesk Patol; 2012 Oct; 48(4):218-21. PubMed ID: 23121032
[TBL] [Abstract][Full Text] [Related]
33. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor.
Lage JM; Berkowitz RS; Rice LW; Goldstein DP; Bernstein MR; Weinberg DS
Obstet Gynecol; 1991 Jan; 77(1):111-5. PubMed ID: 1845777
[TBL] [Abstract][Full Text] [Related]
35. The pattern of hydatidiform moles in Singapore.
Lee YS; Cheah E; Szulman AE
Aust N Z J Obstet Gynaecol; 1981 Nov; 21(4):230-3. PubMed ID: 6951564
[TBL] [Abstract][Full Text] [Related]
36. Distribution of immunocompetent cells in decidua of controlled and uncontrolled (choriocarcinoma/hydatidiform mole) trophoblast invasion.
Knoeller S; Lim E; Aleta L; Hertwig K; Dudenhausen JW; Arck PC
Am J Reprod Immunol; 2003 Jul; 50(1):41-7. PubMed ID: 14506927
[TBL] [Abstract][Full Text] [Related]
37. [Immunohistochemistry of p57 and p53 protein in differential diagnosis of hydropic abortion, partial and complete hydatidiform mole].
Chen YX; Shen DH; Gu YQ; Zhong PP; Xie JL; Song QJ; Zhang YL; Wen J
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):694-7. PubMed ID: 22321550
[TBL] [Abstract][Full Text] [Related]
38. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
39. p53 expression in placentas with hydropic change and hydatidiform moles.
Cheville JC; Robinson RA; Benda JA
Mod Pathol; 1996 Apr; 9(4):392-6. PubMed ID: 8729978
[TBL] [Abstract][Full Text] [Related]
40. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
